Arkolith/Insider Trading/COGT/Form 4

Robbins Andrew R

President and CEO, DirectorCogent Biosciences, Inc. (COGT) · full profile →Form 4 · filed Dec 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2025Tax withholding(F)367K$39.45$14.5M658K
Dec 17, 2025Grant(A)185K—$0185K
Dec 17, 2025Grant(A)840K—$01.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 17, 2025Grant(A)245K—$0245K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-326775) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML